Stock Price
10.81
Daily Change
-0.18 -1.64%
Monthly
2.37%
Yearly
14.88%
Q1 Forecast
11.09

AngioDynamics reported $44.76M in Cash and Equivalent for its fiscal quarter ending in February of 2025.





Cash And Equivalent Change Date
Accuray USD 63.34M 5.93M Sep/2025
AngioDynamics USD 44.76M 9.33M Feb/2025
Artivion USD 73.43M 19.95M Sep/2025
AtriCure USD 167.43M 19.56M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
ICU Medical USD 307.96M 8.23M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
J&J USD 19.71B 1.48B Dec/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Smiths GBP 392M 1.32B Dec/2024
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 217.16B 12.86B Sep/2025
Trinity Biotech USD 1.34M 3.83M Sep/2025